Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Brian C Zanoni, M.D.

Title
Institution
Department
Address

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. K23MH114771 (ZANONI, BRIAN C.) Jul 27, 2018 - Jun 30, 2022
    NIH/NIMH
    InTSHA: Interactive Transition Support for HIV-infected Adolescents Using Social Media
    Role: Principal Investigator
  2. R21HD092132 (ZANONI, BRIAN C.) May 22, 2017 - Apr 30, 2019
    NIH/NICHD
    Outcomes and Predictors of Successful Transition to Adult Care for HIV-infected Adolescents in South Africa
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Archary M, Zanoni B, Lallemant M, Suwannaprom P, Clarke D, Penazzato M. Acceptability and Feasibility of Using Raltegravir Oral Granules for the Treatment of Neonates in a Low-resource Setting. Pediatr Infect Dis J. 2020 01; 39(1):57-60. PMID: 31815839.
    Citations:    
  2. Zanoni BC, Haberer JE. The meaning of "rapid" antiretroviral therapy initiation for adolescents with HIV in sub-Saharan Africa. J Infect Dis. 2019 Nov 04. PMID: 31682259.
    Citations:    
  3. Zanoni BC, Sibaya T, Cairns C, Haberer JE. Barriers to Retention in Care are Overcome by Adolescent-Friendly Services for Adolescents Living with HIV in South Africa: A Qualitative Analysis. AIDS Behav. 2019 Apr; 23(4):957-965. PMID: 30535836.
    Citations:    Fields:    
  4. Kemigisha E, Zanoni B, Bruce K, Menjivar R, Kadengye D, Atwine D, Rukundo GZ. Prevalence of depressive symptoms and associated factors among adolescents living with HIV/AIDS in South Western Uganda. AIDS Care. 2019 10; 31(10):1297-1303. PMID: 30621430.
    Citations:    Fields:    
  5. Zanoni BC, Elliott RJ, Neilan AM, Haberer JE. Screening for HIV and linkage to care in adolescents: insights from a systematic review of recent interventions in high- versus low- and middle-income settings. Adolesc Health Med Ther. 2018; 9:211-235. PMID: 30584383.
    Citations:    
  6. Zanoni BC, Sibaya T, Cairns C, Lammert S, Haberer JE. Higher retention and viral suppression with adolescent-focused HIV clinic in South Africa. PLoS One. 2017; 12(12):e0190260. PMID: 29287088.
    Citations: 1     Fields:    Translation:Humans
  7. Boerma RS, Bunupuradah T, Dow D, Fokam J, Kariminia A, Lehman D, Kityo C, Musiime V, Palumbo P, Schoffelen A, Sophan S, Zanoni B, Rinke de Wit TF, Calis JCJ, Sigaloff KCE. Multicentre analysis of second-line antiretroviral treatment in HIV-infected children: adolescents at high risk of failure. J Int AIDS Soc. 2017 09 15; 20(1):21930. PMID: 28953325.
    Citations:    Fields:    Translation:HumansCells
  8. Georgette N, Siedner MJ, Petty CR, Zanoni BC, Carpenter S, Haberer JE. Impact of a clinical program using weekly Short Message Service (SMS) on antiretroviral therapy adherence support in South Africa: a retrospective cohort study. BMC Med Inform Decis Mak. 2017 Feb 20; 17(1):18. PMID: 28219372.
    Citations: 4     Fields:    Translation:Humans
  9. Georgette N, Siedner MJ, Zanoni B, Sibaya T, Petty CR, Carpenter S, Haberer JE. The Acceptability and Perceived Usefulness of a Weekly Clinical SMS Program to Promote HIV Antiretroviral Medication Adherence in KwaZulu-Natal, South Africa. AIDS Behav. 2016 11; 20(11):2629-2638. PMID: 26781866.
    Citations: 3     Fields:    Translation:Humans
  10. Zanoni BC, Archary M, Buchan S, Katz IT, Haberer JE. Systematic review and meta-analysis of the adolescent HIV continuum of care in South Africa: the Cresting Wave. BMJ Glob Health. 2016; 1(3):e000004. PMID: 28588949.
    Citations: 6     
  11. Zanoni BC, Gandhi RT. Update on opportunistic infections in the era of effective antiretroviral therapy. Infect Dis Clin North Am. 2014 Sep; 28(3):501-18. PMID: 25151568.
    Citations: 5     Fields:    Translation:Humans
  12. Zanoni BC, Mayer KH. The adolescent and young adult HIV cascade of care in the United States: exaggerated health disparities. AIDS Patient Care STDS. 2014 Mar; 28(3):128-35. PMID: 24601734.
    Citations: 70     Fields:    Translation:HumansCells
  13. Mayer KH, Zanoni BC. HIV chemoprophylaxis for adolescents: educable moment, not magic bullet. Clin Infect Dis. 2013 Apr; 56(8):1156-8. PMID: 23223593.
    Citations:    Fields:    Translation:HumansPHPublic Health
  14. Zanoni BC, Sunpath H, Feeney ME. Pediatric response to second-line antiretroviral therapy in South Africa. PLoS One. 2012; 7(11):e49591. PMID: 23185373.
    Citations: 13     Fields:    Translation:Humans
  15. Russo A, Migliorini M, Cecchi L, Cherubini C, Giusti M, Zanoni B, Perri E, Nardi M, Sindona G. Identification and assay of carbohydrates in olive drupes by cesium attachment electrospray tandem mass spectrometry (ESI-MS/MS). J Mass Spectrom. 2012 Sep; 47(9):1242-6. PMID: 22972792.
    Citations:    Fields:    Translation:Animals
  16. Zanoni BC, Phungula T, Zanoni HM, France H, Cook EF, Feeney ME. Predictors of poor CD4 and weight recovery in HIV-infected children initiating ART in South Africa. PLoS One. 2012; 7(3):e33611. PMID: 22438965.
    Citations: 7     Fields:    Translation:Humans
  17. Ruel TD, Zanoni BC, Ssewanyana I, Cao H, Havlir DV, Kamya M, Achan J, Charlebois ED, Feeney ME. Sex differences in HIV RNA level and CD4 cell percentage during childhood. Clin Infect Dis. 2011 Sep; 53(6):592-9. PMID: 21840929.
    Citations: 12     Fields:    Translation:HumansCells
  18. Zanoni BC, Phungula T, Zanoni HM, France H, Feeney ME. Risk factors associated with increased mortality among HIV infected children initiating antiretroviral therapy (ART) in South Africa. PLoS One. 2011; 6(7):e22706. PMID: 21829487.
    Citations: 24     Fields:    Translation:HumansCells
  19. Zanoni BC, Phungula T, Zanoni HM, France H, Feeney ME. Impact of tuberculosis cotreatment on viral suppression rates among HIV-positive children initiating HAART. AIDS. 2011 Jan 02; 25(1):49-55. PMID: 20935555.
    Citations: 15     Fields:    Translation:HumansCells
  20. DeNittis M, Zanoni B, Minati JL, Gorra R, Ambrosoli R. Modelling Biolog profiles' evolution for yeast growth monitoring in alcoholic fermentation. Lett Appl Microbiol. 2011 Feb; 52(2):96-103. PMID: 21175698.
    Citations: 1     Fields:    Translation:AnimalsCells
  21. DeNittis M, Querol A, Zanoni B, Minati JL, Ambrosoli R. Possible use of Biolog methodology for monitoring yeast presence in alcoholic fermentation for wine-making. J Appl Microbiol. 2010 Apr; 108(4):1199-206. PMID: 19796093.
    Citations: 2     Fields:    Translation:AnimalsCells
  22. Zanoni BC. Epidemiology of HIV in southern Africa. Pediatr Radiol. 2009 Jun; 39(6):538-40. PMID: 19277638.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  23. Snyder J, Zanoni BC. Caring comportment and the hospitalist model. Virtual Mentor. 2006 Feb 01; 8(2):114-7. PMID: 23228543.
    Citations:    Fields:    
  24. Kordik CP, Luo C, Zanoni BC, Dax SL, McNally JJ, Lovenberg TW, Wilson SJ, Reitz AB. Aminopyrazoles with high affinity for the human neuropeptide Y5 receptor. Bioorg Med Chem Lett. 2001 Sep 03; 11(17):2283-6. PMID: 11527715.
    Citations: 1     Fields:    Translation:HumansCells
  25. Kordik CP, Luo C, Zanoni BC, Lovenberg TW, Wilson SJ, Vaidya AH, Crooke JJ, Rosenthal DI, Reitz AB. Pyrazolecarboxamide human neuropeptide Y5 receptor ligands with in vivo antifeedant activity. Bioorg Med Chem Lett. 2001 Sep 03; 11(17):2287-90. PMID: 11527716.
    Citations: 2     Fields:    Translation:HumansAnimals
  26. Pagliarini E, Zanoni B, Giovanelli G. Predictive study on Tuscan extra virgin olive oil stability under several commercial conditions. J Agric Food Chem. 2000 Apr; 48(4):1345-51. PMID: 10775395.
    Citations: 2     Fields:    Translation:Humans
  27. Boyer LE, Brazzillo J, Forman MA, Zanoni B. Favorskii Reactions of a Bromoquadricyclanone. J Org Chem. 1996 Oct 18; 61(21):7611-7613. PMID: 11667698.
    Citations:    Fields:    
  28. Zanoni B, Garzaroli C, Anselmi S, Rondinini G. Modeling the growth of Enterococcus faecium in bologna sausage. Appl Environ Microbiol. 1993 Oct; 59(10):3411-7. PMID: 8250562.
    Citations:    Fields:    Translation:AnimalsCellsPHPublic Health
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Zanoni's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (140)
Explore
_
Co-Authors (8)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.